Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.36T, Eli Lilly(LLY) trades at $1,441.00. The stock has a price-to-earnings ratio of 46.89 and currently yields dividends of 0.47%.
During the trading session on 2026-11-13, Eli Lilly(LLY) shares reached a daily high of $1,449.64 and a low of $1,419.81. At a current price of $1,441.00, the stock is +1.5% higher than the low and still -0.6% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 2.08M, versus its average volume of 3.55M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,460.00 and a low of $850.51.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,460.00 and a low of $850.51.
LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is preparing a Phase 1b study of LY38738...
...
george frey / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly breaks ground on $3.5B Pennsylvania manufacturing site for obesity meds Nov 12, 2026, 5:18 PM ET Eli Lilly and Company (LLY) Stock By : Jonathan Block...
Artificial intelligence (AI) is changing every sector, but the magnitude of its impact isn't identical across different industries. Perhaps many investors belie...
Eli Lilly’s (LLY) stock was up as much as 3% on Nov. 12 after China’s medicine regulator approved the sale of the company’s weight-loss pill in the country of 1...
Eli Lilly and Company (NYSE:LLY) has reportedly won Chinese approval for orforglipron, becoming the first company to offer a GLP-1 weight-management pill in the...
Eli Lilly (LLY) China announced that its Orforglipron has been approved by China’s National Medical Products Administration, NMPA, for the launch of a Category...
has become one of the most closely watched stocks in big pharma after a strong multi year run, and the key question now is whether the cash the business can gen...
Eli Lilly (LLY +0.35%) continues to beat expectations, partly thanks to its leadership in the weight loss market. In the third quarter, the company's revenue in...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.